North Star Investment Management’s Organogenesis Holdings ORGO Stock Holding History

North Star Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510	Buy	+210	New	+$513	﹤0.01%	1670

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

North Star Investment Management's ORGO Position: Q2 2026 in Review

North Star Investment Management opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 210 shares worth $510. The stake represents ﹤0.01% of the portfolio and ranks #1670 among its holdings.

136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

North Star Investment Management held 210 shares of Organogenesis Holdings worth $510 as of Q2 2026.
Organogenesis Holdings was a new North Star Investment Management position in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1670 holding.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.